Comparative Effects of Antihypertensives on Proteinuria: Angiotensin-Converting Enzyme Inhibitor Versus α1-Antagonist (Q44110420)

reason for preferred rank

29 November 2017

Comparative Effects of Antihypertensives on Proteinuria: Angiotensin-Converting Enzyme Inhibitor Versus α1-Antagonist (English)

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

22 October 2022

Comparative effects of antihypertensives on proteinuria: angiotensin-converting enzyme inhibitor versus alpha 1-antagonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656730

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

22 October 2022

author name string

M. E. Rosenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656730

22 October 2022

T. H. Hostetter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1656730

22 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1656730

22 October 2022

publication date

1 October 1991

1 reference

full work available at URL

29 November 2017

https://api.elsevier.com/content/article/PII:S0272638612801168?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

https://api.elsevier.com/content/article/PII:S0272638612801168?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

American Journal of Kidney Diseases

22 October 2022

published in

1 reference

29 November 2017

18

1 reference

29 November 2017

4

1 reference

29 November 2017

472-482

1 reference

Association between blood pressure and the rate of decline in renal function with age

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Progression of renal insufficiency: role of blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Reversing glomerular hypertension stabilizes established glomerular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Captopril treatment of hypertension and renal failure in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Renal protective effect of strict blood pressure control with enalapril therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Converting enzyme inhibition in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Prospective randomised trial of early dietary protein restriction in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Effect of colloid volume expansion on glomerular barrier size-selectivity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

THE USE OF SODIUM p-AMINOHIPPURATE FOR THE FUNCTIONAL EVALUATION OF THE HUMAN KIDNEY.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

A method for estimating nitrogen intake of patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Effects of antihypertensive drugs on glomerular morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Captopril improves hypertension and cardiomyopathy in rats with pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Metoprolol and albumin excretion in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Effect of antihypertensive treatment on progression of incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

The modification of diet in renal disease study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

The simple assessment of selectivity in heavy proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980116-8

7 January 2021

Enalapril in the treatment of hypertension associated with impaired renal function

11

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure

22 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

Glomerular and hormonal responses to dietary protein intake in human renal disease

22 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels

22 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

Effect of angiotensin II and norepinephrine on isolated rat afferent and efferent arterioles

22 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control

22 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

Glomerular capillary wall function in human lupus nephritis

22 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(12)80116-8

22 October 2022

Identifiers

1 reference

release_ebka3qhyajfb3pgsbs6lghx3te

29 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ebka3qhyajfb3pgsbs6lghx3te

24 November 2022

mapped directly with Wikidata item

1 reference